# Predictive and Prognostic Value of Inflammatory Markers and microRNA in Stage IV Colorectal Cancer

> **NCT04149613** · — · ENROLLING_BY_INVITATION · sponsor: **American University of Beirut Medical Center** · enrollment: 100 (estimated)

## Conditions studied

- Colorectal Cancer Stage IV

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04149613
- **Lead sponsor:** American University of Beirut Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2018-05-25
- **Primary completion:** 2025-07-15
- **Final completion:** 2026-07-15
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2024-07-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04149613

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04149613, "Predictive and Prognostic Value of Inflammatory Markers and microRNA in Stage IV Colorectal Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04149613. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*